Total Payments
$53,597
2024 Payments
$1,980
Companies
11
Transactions
104
Medicare Patients
1,614
Medicare Billing
$754,126
Payment Breakdown by Category
Other$38,425 (71.7%)
Consulting$8,050 (15.0%)
Travel$3,055 (5.7%)
Food & Beverage$2,277 (4.2%)
Gifts$1,144 (2.1%)
Education$645.79 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38,425 | 25 | 71.7% |
| Consulting Fee | $8,050 | 3 | 15.0% |
| Travel and Lodging | $3,055 | 11 | 5.7% |
| Food and Beverage | $2,277 | 48 | 4.2% |
| Gift | $1,144 | 8 | 2.1% |
| Education | $645.79 | 9 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $31,248 | 44 | $0 (2021) |
| ABBVIE INC. | $15,640 | 22 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $3,689 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,581 | 13 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $645.79 | 9 | $0 (2018) |
| Boston Scientific Corporation | $196.00 | 3 | $0 (2022) |
| Genentech USA, Inc. | $184.44 | 3 | $0 (2024) |
| Celgene Corporation | $155.63 | 2 | $0 (2019) |
| Biogen, Inc. | $119.31 | 2 | $0 (2019) |
| EMD Serono, Inc. | $119.03 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,980 | 7 | ABBVIE INC. ($1,811) |
| 2023 | $12,196 | 17 | ABBVIE INC. ($12,095) |
| 2022 | $1,873 | 6 | ABBVIE INC. ($1,735) |
| 2021 | $12,890 | 6 | Allergan, Inc. ($9,240) |
| 2020 | $4,140 | 5 | Allergan, Inc. ($4,140) |
| 2019 | $10,717 | 23 | Allergan Inc. ($10,295) |
| 2018 | $9,101 | 27 | Allergan Inc. ($7,512) |
| 2017 | $700.24 | 13 | Teva Pharmaceuticals USA, Inc. ($451.99) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $720.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $126.58 | General |
| Category: Neurology | ||||||
| 09/27/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Neurology | ||||||
| 06/03/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $720.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $360.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/12/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $66.17 | General |
| Category: Neurology | ||||||
| 09/14/2023 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Neurology | ||||||
| 09/01/2023 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,840.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Immunology | ||||||
| 08/17/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/20/2023 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $720.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2023 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2023 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2023 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,680.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2023 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $617.80 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2023 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $226.22 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2023 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $180.25 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $47.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/20/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/25/2023 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2022 | Boston Scientific Corporation | Vercise (Device) | Food and Beverage | In-kind items and services | $110.17 | General |
| Category: Vercise_NMD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 396 | 27,662 | $689,482 | $208,003 |
| 2022 | 11 | 442 | 30,762 | $681,959 | $219,641 |
| 2021 | 9 | 410 | 24,894 | $557,351 | $173,828 |
| 2020 | 11 | 366 | 21,541 | $475,612 | $152,654 |
Total Patients
1,614
Total Services
104,859
Medicare Billing
$754,126
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 37 | 27,000 | $459,000 | $134,230 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 115 | 172 | $75,336 | $25,257 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 149 | $46,488 | $15,541 | 33.4% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 27 | 64 | $27,200 | $8,077 | 29.7% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2023 | 29 | 93 | $24,645 | $7,522 | 30.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 39 | 94 | $21,908 | $6,715 | 30.7% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 19 | 44 | $22,000 | $6,337 | 28.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $7,735 | $2,509 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 22 | $4,862 | $1,735 | 35.7% |
| G0372 | Physician service required to establish and document the need for a power mobility device | Office | 2023 | 11 | 11 | $308.00 | $78.93 | 25.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 39 | 30,060 | $461,900 | $145,335 | 31.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 100 | 133 | $55,860 | $19,608 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 160 | $49,920 | $16,740 | 33.5% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 31 | 67 | $25,617 | $8,072 | 31.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 45 | 106 | $21,902 | $8,040 | 36.7% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2022 | 30 | 91 | $22,477 | $7,566 | 33.7% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2022 | 18 | 44 | $19,740 | $6,636 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 51 | $10,761 | $3,950 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $9,120 | $2,208 | 24.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 14 | 14 | $4,186 | $1,363 | 32.6% |
| G0372 | Physician service required to establish and document the need for a power mobility device | Office | 2022 | 17 | 17 | $476.00 | $123.52 | 25.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 45 | 24,300 | $364,500 | $109,418 | 30.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 100 | 137 | $57,540 | $19,352 | 33.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 89 | 145 | $45,240 | $14,945 | 33.0% |
| 64642 | Injection of chemical for destruction of nerve muscles on one arm or leg, 1-4 muscles | Office | 2021 | 39 | 66 | $24,816 | $7,442 | 30.0% |
About Dr. Angeli Mayadev, MD
Dr. Angeli Mayadev, MD is a Physical Medicine & Rehabilitation healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891804530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angeli Mayadev, MD has received a total of $53,597 in payments from pharmaceutical and medical device companies, with $1,980 received in 2024. These payments were reported across 104 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($38,425).
As a Medicare-enrolled provider, Mayadev has provided services to 1,614 Medicare beneficiaries, totaling 104,859 services with total Medicare billing of $754,126. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Seattle, WA
- Active Since 08/29/2006
- Last Updated 06/17/2021
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1891804530
Products in Payments
- BOTOX (Biological) $35,080
- BOTOX (Drug) $10,295
- DYSPORT (Drug) $3,650
- BOTOX COSMETIC (Biological) $1,400
- GILENYA (Drug) $1,249
- KESIMPTA (Drug) $192.75
- Ozanimod (Drug) $155.63
- OCREVUS (Biological) $146.17
- Vercise (Device) $138.58
- COPAXONE (Drug) $121.24
- WATCHMAN (Device) $57.42
- BOTOX - NEURO REHAB (Drug) $39.92
- Dysport (Drug) $38.81
- Ocrevus (Biological) $38.27
- BOTOX - NEUROLOGY (Drug) $35.80
- BOTOX-NEUROLOGY (Drug) $21.67
- TYSABRI (Biological) $19.12
- Betaseron (Drug) $17.99
- BOTOX THERAPEUTIC (Biological) $16.10
- MAYZENT (Drug) $15.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Seattle
Steven Stanos, Do, DO
Physical Medicine & Rehabilitation — Payments: $181,836
Physical Medicine & Rehabilitation $181,836
Martin Childers, Do, Phd, DO, PHD
Physical Medicine & Rehabilitation — Payments: $166,707
Physical Medicine & Rehabilitation $166,707
Dr. Nassim Rad, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $157,428
Physical Medicine & Rehabilitation $157,428
Glen David, Md, MD
Physical Medicine & Rehabilitation — Payments: $14,366
Physical Medicine & Rehabilitation $14,366
Gavin Nixon, Do, DO
Physical Medicine & Rehabilitation — Payments: $7,237
Physical Medicine & Rehabilitation $7,237
Alfred Gellhorn, Md, MD
Physical Medicine & Rehabilitation — Payments: $5,362
Physical Medicine & Rehabilitation $5,362